Use of dual action inhibitor (duloxetine) in diabetic neuropathy
Невропатическая боль при сахарном диабете имеет сложный характер и вызывается в отличие от ноцицептив- ной боли ? нарушениями как в периферической, так и центральной нервной системе. Накапливается все больше данных, свидетель- ствующих о целом спектре нарушений, включая изменения струк- туры и функц...
Main Author: | Irina Vladimirovna Gur'eva |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2009-03-01
|
Series: | Сахарный диабет |
Subjects: | |
Online Access: | https://www.dia-endojournals.ru/jour/article/view/5424 |
Similar Items
-
Clinico-expert diagnostics of gastrointestinal form of diabetic neuropathy
by: Irina Alekseevna Kurnikova, et al.
Published: (2011-06-01) -
COMPARATIVE STUDY OF EFFECTIVENESS OF VENLAFAXINE, DULOXETINE AND SERTRALINE IN MANAGEMENT OF DIABETIC SENSORY NEUROPATHY
by: Nabila Shaukat, et al.
Published: (2021-02-01) -
Analgesic Effect of Duloxetine Compared to Nortryptiline in Patients with painful Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Trial
by: Mohammadali Bayani, et al.
Published: (2021-01-01) -
Diagnosis and rational treatment of painful diabetic peripheral neuropathy: an interdisciplinary expert consensus
by: Gagik R. Galstyan, et al.
Published: (2019-10-01) -
A Systematic Guideline by the ASPN Workgroup on the Evidence, Education, and Treatment Algorithm for Painful Diabetic Neuropathy: SWEET
by: Sayed D, et al.
Published: (2024-04-01)